Biomarkers of Treatment Response in Sarcoma

In the evolving landscape of modern medicine, biomarkers are at the forefront of clinical research. Biomarkers can serve as objective measures of treatment response, guiding patients towards the most suitable therapies and reducing the risk of unnecessary and potentially harmful treatments.

0 min read
Written by
Elizabeth Bolitho
  • Categories
  • Biomarkers
Receive the latest newsletter directly to your inbox

Biomarkers of Treatment Response

Sarcoma – A Rare Disease with Unmet Need

Biomarkers of Treatment Response

MDM2: A Potential Biomarker of Doxorubicin Response


    More on Biomarkers